Eagle Asset Management Inc
- SEC CIK
- 0000790502
- Latest filing
- Nov 12, 2024
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by Eagle Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q3 2024 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −676,136−100.0% | Sold out | Holders |
| Q2 2024 | 676,136 | $55.5M | 0.3% | −36,393−5.1% | Reduced | Holders |
| Q1 2024 | 712,529 | $62.1M | 0.3% | +276,250+63.3% | Added | Holders |
| Q4 2023 | 436,279 | $42.1M | 0.2% | −1,812−0.4% | Reduced | Holders |
| Q3 2023 | 438,091 | $38.8M | 0.2% | −190.0% | Reduced | Holders |
| Q2 2023 | 438,110 | $38.0M | 0.2% | +438,110 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −564,702−100.0% | Sold out | Holders |
| Q1 2021 | 564,702 | $44.0M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.